• Neurotensin for GPCR Trafficking Workflows

  2026-09-16

  Build more interpretable NTR1 experiments with Neurotensin, from receptor-trafficking assays to miR-133α measurements in gastrointestinal cells. This practical guide combines peptide handling, time-resolved workflow design, and spectral-interference controls informed by recent fluorescence-classification research.

• 10 mM dNTP Mixture for DNA Workflows

  2026-09-16

  Build more reproducible PCR, sequencing, and DNA synthesis workflows with a defined equimolar nucleotide source. This practical guide also shows how standardized DNA preparation can strengthen LNP trafficking assays without confusing upstream reagent quality with intracellular delivery performance.

• Caveolin-1, Cholesterol Homeostasis, and MASLD

  2026-09-15

  The reference study identifies caveolin-1 (CAV1) as a regulator of hepatic cholesterol homeostasis whose loss aggravates endoplasmic reticulum stress and pyroptosis during metabolic dysfunction-associated steatotic liver disease. Its combination of CAV1-deficient mice, liver transcriptomics, human samples, and in vitro validation connects the FXR/NR1H4–ABCG5/ABCG8 axis with disease progression and provides a mechanistic framework for studying cholesterol-driven liver injury.

• FK866 (APO866) Workflows for NAMPT Research

  2026-09-15

  FK866 (APO866) gives researchers a time-controlled way to interrogate NAMPT dependence, NAD depletion, and mitochondrial injury in leukemia models. This guide connects hematologic cancer research with a carefully bounded macrophage host-defense application while emphasizing dosing, assay design, and troubleshooting.

• Rocilinostat (ACY-1215) Experimental Workflows

  2026-09-14

  Build selective HDAC6 experiments around α-tubulin acetylation, multiple myeloma viability, and proteasome-inhibitor combinations. This guide also shows how the SMPD4 primary-cilia study can inform exploratory neurodevelopment assays without confusing mechanistic hypotheses with validated findings.

• From dNTP Precision to Smarter Nucleic Acid Delivery

  2026-09-14

  A translational perspective on how a defined 10 mM dNTP mixture supports reproducible DNA synthesis while informing a broader strategy for nucleic acid delivery studies. The article connects nucleotide-pool control with emerging evidence that LNP surface charge and target-cell V-ATPase activity jointly shape delivery performance.

• RIPA Lysis Buffer (Strong): Decode BBB Signaling

  2026-09-13

  RIPA Lysis Buffer (Strong) provides a rigorous foundation for protein extraction from cultured brain cells and animal tissues. This guide connects detergent chemistry with blood–brain barrier assay design, showing how lysate strategy can preserve mechanistic interpretation rather than merely maximize yield.

• Neomycin sulfate: RNA/DNA Assay Workflows

  2026-09-12

  Neomycin sulfate is more than a conventional antimicrobial control: it is a tunable probe for ribozyme catalysis, viral RNA recognition, DNA triplexes, and ryanodine receptor function. This workflow connects defined molecular assays with microbiome–immune research while emphasizing controls, fresh solution handling, and domain-specific troubleshooting.

• Carbapenemase Gene Spread in Enterobacter cloacae

  2026-09-11

  Chen et al. integrated gene localization, antimicrobial susceptibility testing, plasmid conjugation, mobile-element profiling, and ERIC-PCR to examine carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The study identifies plasmid-associated blaNDM-1 as a major dissemination risk and shows why resistance surveillance must distinguish clonal spread from horizontal gene transfer.

• Pollen Interference in EEM Bioaerosol Classification

  2026-09-11

  The reference study shows that pollen can compromise excitation–emission matrix fluorescence-based classification of hazardous bioaerosols, but spectral preprocessing and fast Fourier transform features can substantially improve discrimination. Its random-forest workflow reached 89.24% accuracy across 31 sample types, providing a practical computational strategy for reducing pollen-associated misclassification.

• Calpeptin Workflows for Fibrosis Research

  2026-09-10

  Build reproducible calpain-inhibition experiments with Calpeptin, from cell-based fibrosis assays to extracellular-vesicle release studies. This guide separates literature-backed findings from practical starting conditions and shows how to troubleshoot solubility, cytotoxicity, and residual-vesicle effects.

• Demethyleneberberine: From Pathway to Phenotype

  2026-09-10

  Demethyleneberberine (DMB) is a mechanistically versatile research compound whose value lies in connecting pathway modulation with measurable cellular phenotypes. This guide shows how to select endpoints, controls, concentrations, and disease-model readouts for reproducible inflammation and NSCLC studies.

• B. fragilis, Vagal Cholinergic Signaling, and Seizures

  2026-09-09

  Jia et al. identify a mechanistic gut–vagus–brain pathway through which Bacteroides fragilis suppresses seizures, linking colonic ChAT-positive cells, vagal transmission, and intestinal Lactobacillus enrichment. The study combines mouse circuit experiments with a pediatric randomized trial, providing a useful framework for evaluating microbiota-directed therapies in refractory epilepsy.

• Cheminformatics Design of Optimized Small-Molecule Libraries

  2026-09-09

  Moret et al. introduce a data-driven framework for comparing and designing small-molecule collections using target coverage, binding selectivity, cellular phenotypes, chemical structure, clinical development status, and user preferences. Applied to kinase and mechanism-of-action libraries, the approach reduced redundant off-target activity while improving coverage, providing a practical foundation for more interpretable chemical-genetic experiments.

• SGI-1027 Induces Apoptosis in Huh7 Cells

  2026-09-08

  The reference study shows that the non-nucleoside DNMT inhibitor SGI-1027 reduces Huh7 hepatocellular carcinoma cell viability primarily through apoptosis rather than detectable cell-cycle redistribution. Its integration of viability, flow cytometry, TUNEL staining, and BCL-2/BAX immunoblotting provides a useful framework for evaluating epigenetic anticancer mechanisms while highlighting the limits of extrapolating from one in vitro model.

3596 records 1/240 page Next 12345 下5页 Last page